SR9 Stock Chart & Stats
€146.45
€1.85(1.28%)
At close: 4:00 PM EDT
€146.45
€1.85(1.28%)
Day’s Range― - ―
52-Week Range€124.75 - €166.70
Previous CloseN/A
Volume265.00
Average Volume (3M)2.04K
Market Cap
€40.39B
Enterprise Value€45.68K
Total Cash (Recent Filing)€3.94B
Total Debt (Recent Filing)€9.47B
Price to Earnings (P/E)10.5
Beta0.77
Next Earnings
Nov 05, 2026EPS Estimate
2.95Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)16.58
Shares Outstanding298,761,720
10 Day Avg. Volume4,664
30 Day Avg. Volume2,044
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)2.03
Price to Sales (P/S)1.00
P/FCF Ratio15.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€131.00Price Target Upside-10.55% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering7
EPS Forecast (FY)17.43
Revenue Forecast (FY)€45.63B
Bulls Say, Bears Say
Bulls Say
Strong Profitability And UnderwritingHigh returns and a strong P&C underwriting result indicate effective risk selection, pricing discipline and capital deployment. Sustained underwriting quality can support earnings resilience across the insurance cycle, even when catastrophe experience normalizes.
Improved Capital Strength And LeverageLower leverage, stronger equity and a high solvency ratio provide capacity to absorb claims volatility, support growth and maintain shareholder distributions. This balance-sheet flexibility is a durable competitive advantage in capital-intensive reinsurance.
Reliable Cash And Investment IncomeConsistently positive operating and free cash flow, combined with recurring investment income, supports claims payments, capital needs and distributions. Swiss Re's large investment portfolio also adds an important earnings stream beyond underwriting.
Bears Say
Declining New-business ProfitabilityLower new-business CSM across all major segments signals weaker economics on newly written contracts, reflecting reduced transaction activity and competition. If persistent, this could constrain future growth in contractual service margins and earnings.
Pricing Pressure And Higher Loss AssumptionsCompetitive pricing and rising loss assumptions pressure margins on new and renewed business. A prolonged mismatch between premium rates and underlying risk costs could weaken underwriting profitability and make disciplined volume management necessary.
Catastrophe And Expense-ratio VolatilityResults benefited materially from unusually favorable catastrophe experience that may not persist through the full season. At the same time, a rising expense ratio can reduce operating leverage, leaving earnings exposed to claims normalization and cost inflation.
Swiss Re AG News
SR9 FAQ
What was Swiss Re AG’s price range in the past 12 months?
Swiss Re AG lowest stock price was €124.75 and its highest was €166.70 in the past 12 months.
What is Swiss Re AG’s market cap?
Swiss Re AG’s market cap is €40.39B.
When is Swiss Re AG’s upcoming earnings report date?
Swiss Re AG’s upcoming earnings report date is Nov 05, 2026 which is in 72 days.
How were Swiss Re AG’s earnings last quarter?
Swiss Re AG released its earnings results on Aug 06, 2026. The company reported €3.845 earnings per share for the quarter, beating the consensus estimate of €3.464 by €0.382.
Is Swiss Re AG overvalued?
According to Wall Street analysts Swiss Re AG’s price is currently Overvalued.
Does Swiss Re AG pay dividends?
Swiss Re AG does not currently pay dividends.
What is Swiss Re AG’s EPS estimate?
Swiss Re AG’s EPS estimate is 2.95.
How many shares outstanding does Swiss Re AG have?
Swiss Re AG has 298,761,720 shares outstanding.
What happened to Swiss Re AG’s price movement after its last earnings report?
Swiss Re AG reported an EPS of €3.845 in its last earnings report, beating expectations of €3.464. Following the earnings report the stock price went up 1.172%.
Which hedge fund is a major shareholder of Swiss Re AG?
Currently, no hedge funds are holding shares in DE:SR9
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Swiss Re AG
Swiss Re AG, along with its affiliated entities, operates internationally as a prominent provider of diverse risk management solutions. Its offerings extend to wholesale reinsurance, direct insurance products, various forms of insurance-based risk transfer, and associated services. The company's extensive operations are primarily channeled through three key business divisions: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. Specifically, the Property & Casualty Reinsurance unit undertakes the underwriting of a comprehensive array of risks. This includes property-related coverages like general property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative solutions. It also encompasses casualty reinsurance for areas such as general liability, motor vehicle, workers' compensation, personal accident, management and professional liability, and cyber threats, alongside facultative options. The Life & Health Reinsurance segment specializes in underwriting solutions for both life and health insurance portfolios. The Corporate Solutions division provides tailored risk transfer products, ranging from standardized covers and multi-line programs to highly customized insurance solutions for businesses. Its extensive client base spans various sectors, including stock and mutual insurance carriers, government and public bodies, medium to large enterprises, and private individuals. Established in 1863, the company maintains its headquarters in Zurich, Switzerland.
SR9 Company Deck
SR9 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a predominantly positive operational and financial picture: strong H1 profitability (USD 2.8bn net income), high ROE (23%), excellent P&C underwriting (76.7% combined ratio), robust Life & Health results, solid investment returns (4.0% ROI), and very strong capital metrics (SST ~264%). Management also highlighted disciplined cycle management, increased cost-savings targets (USD 500m), and prudent reserving actions that reinforce balance sheet resilience. Offsetting these positives are meaningful declines in new business CSM across divisions (notably Life & Health), pricing and competitive pressures in particular lines (nonproportional property, specialty), a risk-adjusted price decline explained by higher loss assumptions (~4.4%), an upward trend in expense ratios, and the risk that benign nat cat experience in H1 may not persist into peak hurricane season. Overall, the positives (profitability, capital strength, underwriting performance and active prudence) outweigh the headwinds from new-business profitability and line-specific pricing pressure, though these headwinds warrant monitoring.View all DE:SR9 earnings summariesSR9 Stock 12 Month Forecast
Average Price Target
€131.00
▼(-10.55% Downside)